SALT LAKE CITY – DEA Acting Administrator Uttam Dhillon today highlighted the significance of law enforcement as part of a successful, comprehensive solution to the opioid epidemic, stressing efforts aimed at those supplying communities with deadly, addictive drugs. Acting Administrator Dhillon delivered remarks to hundreds of medical practitioners, drug treatment...

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...

NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

WASHINGTON – The Office of Justice Programs’ Bureau of Justice Assistance today released the Fentanyl Safety Recommendations for First Responders’ companion training video Fentanyl: The Real Deal. The video was produced by U.S. Customs and Border Protection to help first responders protect themselves when the presence of fentanyl is suspected...

WASHINGTON - While in Cleveland, Ohio, Attorney General Jeff Sessions today announced the unsealing of a 43-count indictment in federal court in Cleveland, which charges two Chinese citizens with operating a conspiracy that manufactured and shipped deadly fentanyl analogues and 250 other drugs to at least 25 countries and 37...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...

ST. LOUIS - William J. Callahan, III was appointed Special Agent-in-Charge (SAC) of the DEA St. Louis Division and reported for duty on July 10, 2018. SAC Callahan is already hard at work finding innovative ways to tackle the drug and gang related violence that has been plaguing Missouri, Kansas...

WASHINGTON – The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication...